Loading…
Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study
Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remain...
Saved in:
Published in: | PloS one 2011-09, Vol.6 (9), p.e23715-e23715 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203 |
---|---|
cites | cdi_FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203 |
container_end_page | e23715 |
container_issue | 9 |
container_start_page | e23715 |
container_title | PloS one |
container_volume | 6 |
creator | Feng, Jia-Yih Su, Wei-Juin Chiu, Yu-Chi Huang, Shiang-Fen Lin, Yung-Yang Huang, Ruay-Ming Lin, Ching-Hsiung Hwang, Jhi-Jhu Lee, Jen-Jyh Yu, Ming-Chih Yu, Kwok-Woon Lee, Yu-Chin |
description | Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remains an issue of controversy.
This prospective observational study enrolled newly diagnosed, culture-proven pulmonary tuberculosis patients from five medical centers and one regional hospital, which were referral hospitals of TB patients. Radiographic findings and clinical symptoms were determined at the time of diagnosis. Patients who died for any reason during the course of anti-TB treatment were defined as mortality cases and death that occurred within 30 days of initiating treatment was defined as early mortality. Clinical factors associated with overall mortality and early mortality were investigated.
A total of 992 patients were enrolled and 195 (19.7%) died. Nearly one-third (62/195, 31.8%) of the deaths occurred before or within 30 days of treatment initiation. Older age (RR = 1.04, 95%CI: 1.03-1.05), malignancy (RR = 2.42, 95%CI: 1.77-3.31), renal insufficiency (RR = 1.77, 95%CI: 1.12-2.80), presence of chronic cough (RR = 0.63, 95%CI: 0.47-0.84), fever (RR = 1.45, 95%CI: 1.09-1.94), and anorexia (RR = 1.49, 95%CI: 1.07-2.06) were independently associated with overall mortality. Kaplan-Meier survival analysis demonstrated significantly higher mortality in patients present with fever (p |
doi_str_mv | 10.1371/journal.pone.0023715 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1309103306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476880108</galeid><doaj_id>oai_doaj_org_article_ed221c49191d4376a3d1b5fcdadfd2ea</doaj_id><sourcerecordid>A476880108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203</originalsourceid><addsrcrecordid>eNqNk02L2zAQhk1p6W7T_oPSGgotPTiVLFuyL4Vl6UdgYaFfVyFLcqIgW64kh-bfd5J4l7jsofhge_S8rzQzmiR5idESE4Y_bN3oe2GXg-v1EqEcYuWj5BLXJM9ojsjjs--L5FkIW4RKUlH6NLnIYQVTjC6TbtWbaIRNB6-D7qOIxvXh8KeMjGnnfBTWxH1q-nQYbed64fdpHBvt5WhdMMCCBpQhywToXBi0jGanU9cE7XdHQ_APcVT758mTVtigX0zvRfLz86cf11-zm9svq-urm0yyksWMFo1sKYWMClEgqXXeorKmskZKKkxlWbYVazRmFDGNWFlI1SDdAsYUayDfRfL65DvAEflUqcAxQTVGhCAKxOpEKCe2fPCmg7y4E4YfA86vufDRSKu5VnmOZVHjGquCMCqIwk3ZSiVUq3ItwOvjtNvYdFpJKIYXdmY6X-nNhq_djhPM8hw6t0jeTQbe_R51iLwzQWprRa_dGHhVE2hXzkog3_xDPpzcRK0FnN_0rYNt5cGTXxWMVhXCqAJq-QAFj9KdkXCrWgPxmeD9TABM1H_iWowh8NX3b__P3v6as2_P2I0WNm6Cs-PxKs7B4gRKuGbB6_a-xhjxw1DcVYMfhoJPQwGyV-f9uRfdTQH5CyGZCpU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1309103306</pqid></control><display><type>article</type><title>Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Feng, Jia-Yih ; Su, Wei-Juin ; Chiu, Yu-Chi ; Huang, Shiang-Fen ; Lin, Yung-Yang ; Huang, Ruay-Ming ; Lin, Ching-Hsiung ; Hwang, Jhi-Jhu ; Lee, Jen-Jyh ; Yu, Ming-Chih ; Yu, Kwok-Woon ; Lee, Yu-Chin</creator><contributor>Cattamanchi, Adithya</contributor><creatorcontrib>Feng, Jia-Yih ; Su, Wei-Juin ; Chiu, Yu-Chi ; Huang, Shiang-Fen ; Lin, Yung-Yang ; Huang, Ruay-Ming ; Lin, Ching-Hsiung ; Hwang, Jhi-Jhu ; Lee, Jen-Jyh ; Yu, Ming-Chih ; Yu, Kwok-Woon ; Lee, Yu-Chin ; Cattamanchi, Adithya</creatorcontrib><description>Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remains an issue of controversy.
This prospective observational study enrolled newly diagnosed, culture-proven pulmonary tuberculosis patients from five medical centers and one regional hospital, which were referral hospitals of TB patients. Radiographic findings and clinical symptoms were determined at the time of diagnosis. Patients who died for any reason during the course of anti-TB treatment were defined as mortality cases and death that occurred within 30 days of initiating treatment was defined as early mortality. Clinical factors associated with overall mortality and early mortality were investigated.
A total of 992 patients were enrolled and 195 (19.7%) died. Nearly one-third (62/195, 31.8%) of the deaths occurred before or within 30 days of treatment initiation. Older age (RR = 1.04, 95%CI: 1.03-1.05), malignancy (RR = 2.42, 95%CI: 1.77-3.31), renal insufficiency (RR = 1.77, 95%CI: 1.12-2.80), presence of chronic cough (RR = 0.63, 95%CI: 0.47-0.84), fever (RR = 1.45, 95%CI: 1.09-1.94), and anorexia (RR = 1.49, 95%CI: 1.07-2.06) were independently associated with overall mortality. Kaplan-Meier survival analysis demonstrated significantly higher mortality in patients present with fever (p<0.001), anorexia (p = 0.005), and without chronic cough (p<0.001). Among patients of mortality, those with respiratory symptoms of chronic cough (RR = 0.56, 95%CI: 0.33-0.98) and dyspnea (HR = 0.51, 95%CI: 0.27-0.98) were less likely to experience early mortality. The radiological features were comparable between survivors and non-survivors.
In addition to demographic characteristics, clinical presentations including the presence of fever, anorexia, and the absence of chronic cough, were also independent predictors for on-treatment mortality in pulmonary tuberculosis patients.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0023715</identifier><identifier>PMID: 21931610</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aged ; Analysis ; Anorexia ; Clinical medicine ; Cough ; Demographics ; Disease ; Drug resistance ; Dyspnea ; Early experience ; Epidemiology ; Ethics ; Female ; Fever ; Genotype ; Genotype & phenotype ; Health care facilities ; Health risks ; HIV ; Hospitals ; Human immunodeficiency virus ; Humans ; Infections ; Intensive care ; Internal medicine ; Kidneys ; Male ; Malignancy ; Medical centers ; Medical diagnosis ; Medical laboratories ; Medical research ; Medicine ; Middle Aged ; Mortality ; Mycobacterium - genetics ; Mycobacterium tuberculosis ; Observational studies ; Patient outcomes ; Patients ; Prognosis ; Prospective Studies ; Public health ; Pulmonary tuberculosis ; Renal insufficiency ; Respiration ; Review boards ; Risk analysis ; Risk factors ; Studies ; Survival Rate ; Tuberculosis ; Tuberculosis, Pulmonary - diagnosis ; Tuberculosis, Pulmonary - microbiology ; Tuberculosis, Pulmonary - mortality</subject><ispartof>PloS one, 2011-09, Vol.6 (9), p.e23715-e23715</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Feng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Feng et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203</citedby><cites>FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1309103306/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1309103306?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21931610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Cattamanchi, Adithya</contributor><creatorcontrib>Feng, Jia-Yih</creatorcontrib><creatorcontrib>Su, Wei-Juin</creatorcontrib><creatorcontrib>Chiu, Yu-Chi</creatorcontrib><creatorcontrib>Huang, Shiang-Fen</creatorcontrib><creatorcontrib>Lin, Yung-Yang</creatorcontrib><creatorcontrib>Huang, Ruay-Ming</creatorcontrib><creatorcontrib>Lin, Ching-Hsiung</creatorcontrib><creatorcontrib>Hwang, Jhi-Jhu</creatorcontrib><creatorcontrib>Lee, Jen-Jyh</creatorcontrib><creatorcontrib>Yu, Ming-Chih</creatorcontrib><creatorcontrib>Yu, Kwok-Woon</creatorcontrib><creatorcontrib>Lee, Yu-Chin</creatorcontrib><title>Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remains an issue of controversy.
This prospective observational study enrolled newly diagnosed, culture-proven pulmonary tuberculosis patients from five medical centers and one regional hospital, which were referral hospitals of TB patients. Radiographic findings and clinical symptoms were determined at the time of diagnosis. Patients who died for any reason during the course of anti-TB treatment were defined as mortality cases and death that occurred within 30 days of initiating treatment was defined as early mortality. Clinical factors associated with overall mortality and early mortality were investigated.
A total of 992 patients were enrolled and 195 (19.7%) died. Nearly one-third (62/195, 31.8%) of the deaths occurred before or within 30 days of treatment initiation. Older age (RR = 1.04, 95%CI: 1.03-1.05), malignancy (RR = 2.42, 95%CI: 1.77-3.31), renal insufficiency (RR = 1.77, 95%CI: 1.12-2.80), presence of chronic cough (RR = 0.63, 95%CI: 0.47-0.84), fever (RR = 1.45, 95%CI: 1.09-1.94), and anorexia (RR = 1.49, 95%CI: 1.07-2.06) were independently associated with overall mortality. Kaplan-Meier survival analysis demonstrated significantly higher mortality in patients present with fever (p<0.001), anorexia (p = 0.005), and without chronic cough (p<0.001). Among patients of mortality, those with respiratory symptoms of chronic cough (RR = 0.56, 95%CI: 0.33-0.98) and dyspnea (HR = 0.51, 95%CI: 0.27-0.98) were less likely to experience early mortality. The radiological features were comparable between survivors and non-survivors.
In addition to demographic characteristics, clinical presentations including the presence of fever, anorexia, and the absence of chronic cough, were also independent predictors for on-treatment mortality in pulmonary tuberculosis patients.</description><subject>Aged</subject><subject>Analysis</subject><subject>Anorexia</subject><subject>Clinical medicine</subject><subject>Cough</subject><subject>Demographics</subject><subject>Disease</subject><subject>Drug resistance</subject><subject>Dyspnea</subject><subject>Early experience</subject><subject>Epidemiology</subject><subject>Ethics</subject><subject>Female</subject><subject>Fever</subject><subject>Genotype</subject><subject>Genotype & phenotype</subject><subject>Health care facilities</subject><subject>Health risks</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Intensive care</subject><subject>Internal medicine</subject><subject>Kidneys</subject><subject>Male</subject><subject>Malignancy</subject><subject>Medical centers</subject><subject>Medical diagnosis</subject><subject>Medical laboratories</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mycobacterium - genetics</subject><subject>Mycobacterium tuberculosis</subject><subject>Observational studies</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Public health</subject><subject>Pulmonary tuberculosis</subject><subject>Renal insufficiency</subject><subject>Respiration</subject><subject>Review boards</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Studies</subject><subject>Survival Rate</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Pulmonary - diagnosis</subject><subject>Tuberculosis, Pulmonary - microbiology</subject><subject>Tuberculosis, Pulmonary - mortality</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk02L2zAQhk1p6W7T_oPSGgotPTiVLFuyL4Vl6UdgYaFfVyFLcqIgW64kh-bfd5J4l7jsofhge_S8rzQzmiR5idESE4Y_bN3oe2GXg-v1EqEcYuWj5BLXJM9ojsjjs--L5FkIW4RKUlH6NLnIYQVTjC6TbtWbaIRNB6-D7qOIxvXh8KeMjGnnfBTWxH1q-nQYbed64fdpHBvt5WhdMMCCBpQhywToXBi0jGanU9cE7XdHQ_APcVT758mTVtigX0zvRfLz86cf11-zm9svq-urm0yyksWMFo1sKYWMClEgqXXeorKmskZKKkxlWbYVazRmFDGNWFlI1SDdAsYUayDfRfL65DvAEflUqcAxQTVGhCAKxOpEKCe2fPCmg7y4E4YfA86vufDRSKu5VnmOZVHjGquCMCqIwk3ZSiVUq3ItwOvjtNvYdFpJKIYXdmY6X-nNhq_djhPM8hw6t0jeTQbe_R51iLwzQWprRa_dGHhVE2hXzkog3_xDPpzcRK0FnN_0rYNt5cGTXxWMVhXCqAJq-QAFj9KdkXCrWgPxmeD9TABM1H_iWowh8NX3b__P3v6as2_P2I0WNm6Cs-PxKs7B4gRKuGbB6_a-xhjxw1DcVYMfhoJPQwGyV-f9uRfdTQH5CyGZCpU</recordid><startdate>20110913</startdate><enddate>20110913</enddate><creator>Feng, Jia-Yih</creator><creator>Su, Wei-Juin</creator><creator>Chiu, Yu-Chi</creator><creator>Huang, Shiang-Fen</creator><creator>Lin, Yung-Yang</creator><creator>Huang, Ruay-Ming</creator><creator>Lin, Ching-Hsiung</creator><creator>Hwang, Jhi-Jhu</creator><creator>Lee, Jen-Jyh</creator><creator>Yu, Ming-Chih</creator><creator>Yu, Kwok-Woon</creator><creator>Lee, Yu-Chin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110913</creationdate><title>Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study</title><author>Feng, Jia-Yih ; Su, Wei-Juin ; Chiu, Yu-Chi ; Huang, Shiang-Fen ; Lin, Yung-Yang ; Huang, Ruay-Ming ; Lin, Ching-Hsiung ; Hwang, Jhi-Jhu ; Lee, Jen-Jyh ; Yu, Ming-Chih ; Yu, Kwok-Woon ; Lee, Yu-Chin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Analysis</topic><topic>Anorexia</topic><topic>Clinical medicine</topic><topic>Cough</topic><topic>Demographics</topic><topic>Disease</topic><topic>Drug resistance</topic><topic>Dyspnea</topic><topic>Early experience</topic><topic>Epidemiology</topic><topic>Ethics</topic><topic>Female</topic><topic>Fever</topic><topic>Genotype</topic><topic>Genotype & phenotype</topic><topic>Health care facilities</topic><topic>Health risks</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Intensive care</topic><topic>Internal medicine</topic><topic>Kidneys</topic><topic>Male</topic><topic>Malignancy</topic><topic>Medical centers</topic><topic>Medical diagnosis</topic><topic>Medical laboratories</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mycobacterium - genetics</topic><topic>Mycobacterium tuberculosis</topic><topic>Observational studies</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Public health</topic><topic>Pulmonary tuberculosis</topic><topic>Renal insufficiency</topic><topic>Respiration</topic><topic>Review boards</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Studies</topic><topic>Survival Rate</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Pulmonary - diagnosis</topic><topic>Tuberculosis, Pulmonary - microbiology</topic><topic>Tuberculosis, Pulmonary - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Jia-Yih</creatorcontrib><creatorcontrib>Su, Wei-Juin</creatorcontrib><creatorcontrib>Chiu, Yu-Chi</creatorcontrib><creatorcontrib>Huang, Shiang-Fen</creatorcontrib><creatorcontrib>Lin, Yung-Yang</creatorcontrib><creatorcontrib>Huang, Ruay-Ming</creatorcontrib><creatorcontrib>Lin, Ching-Hsiung</creatorcontrib><creatorcontrib>Hwang, Jhi-Jhu</creatorcontrib><creatorcontrib>Lee, Jen-Jyh</creatorcontrib><creatorcontrib>Yu, Ming-Chih</creatorcontrib><creatorcontrib>Yu, Kwok-Woon</creatorcontrib><creatorcontrib>Lee, Yu-Chin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Jia-Yih</au><au>Su, Wei-Juin</au><au>Chiu, Yu-Chi</au><au>Huang, Shiang-Fen</au><au>Lin, Yung-Yang</au><au>Huang, Ruay-Ming</au><au>Lin, Ching-Hsiung</au><au>Hwang, Jhi-Jhu</au><au>Lee, Jen-Jyh</au><au>Yu, Ming-Chih</au><au>Yu, Kwok-Woon</au><au>Lee, Yu-Chin</au><au>Cattamanchi, Adithya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2011-09-13</date><risdate>2011</risdate><volume>6</volume><issue>9</issue><spage>e23715</spage><epage>e23715</epage><pages>e23715-e23715</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remains an issue of controversy.
This prospective observational study enrolled newly diagnosed, culture-proven pulmonary tuberculosis patients from five medical centers and one regional hospital, which were referral hospitals of TB patients. Radiographic findings and clinical symptoms were determined at the time of diagnosis. Patients who died for any reason during the course of anti-TB treatment were defined as mortality cases and death that occurred within 30 days of initiating treatment was defined as early mortality. Clinical factors associated with overall mortality and early mortality were investigated.
A total of 992 patients were enrolled and 195 (19.7%) died. Nearly one-third (62/195, 31.8%) of the deaths occurred before or within 30 days of treatment initiation. Older age (RR = 1.04, 95%CI: 1.03-1.05), malignancy (RR = 2.42, 95%CI: 1.77-3.31), renal insufficiency (RR = 1.77, 95%CI: 1.12-2.80), presence of chronic cough (RR = 0.63, 95%CI: 0.47-0.84), fever (RR = 1.45, 95%CI: 1.09-1.94), and anorexia (RR = 1.49, 95%CI: 1.07-2.06) were independently associated with overall mortality. Kaplan-Meier survival analysis demonstrated significantly higher mortality in patients present with fever (p<0.001), anorexia (p = 0.005), and without chronic cough (p<0.001). Among patients of mortality, those with respiratory symptoms of chronic cough (RR = 0.56, 95%CI: 0.33-0.98) and dyspnea (HR = 0.51, 95%CI: 0.27-0.98) were less likely to experience early mortality. The radiological features were comparable between survivors and non-survivors.
In addition to demographic characteristics, clinical presentations including the presence of fever, anorexia, and the absence of chronic cough, were also independent predictors for on-treatment mortality in pulmonary tuberculosis patients.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21931610</pmid><doi>10.1371/journal.pone.0023715</doi><tpages>e23715</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2011-09, Vol.6 (9), p.e23715-e23715 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1309103306 |
source | PubMed (Medline); Publicly Available Content Database |
subjects | Aged Analysis Anorexia Clinical medicine Cough Demographics Disease Drug resistance Dyspnea Early experience Epidemiology Ethics Female Fever Genotype Genotype & phenotype Health care facilities Health risks HIV Hospitals Human immunodeficiency virus Humans Infections Intensive care Internal medicine Kidneys Male Malignancy Medical centers Medical diagnosis Medical laboratories Medical research Medicine Middle Aged Mortality Mycobacterium - genetics Mycobacterium tuberculosis Observational studies Patient outcomes Patients Prognosis Prospective Studies Public health Pulmonary tuberculosis Renal insufficiency Respiration Review boards Risk analysis Risk factors Studies Survival Rate Tuberculosis Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - microbiology Tuberculosis, Pulmonary - mortality |
title | Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A03%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initial%20presentations%20predict%20mortality%20in%20pulmonary%20tuberculosis%20patients--a%20prospective%20observational%20study&rft.jtitle=PloS%20one&rft.au=Feng,%20Jia-Yih&rft.date=2011-09-13&rft.volume=6&rft.issue=9&rft.spage=e23715&rft.epage=e23715&rft.pages=e23715-e23715&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0023715&rft_dat=%3Cgale_plos_%3EA476880108%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c757t-64bcf663714a40cee2f0596c90dcd16c55f87be17607e0754cdb0efe2f7d7b203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1309103306&rft_id=info:pmid/21931610&rft_galeid=A476880108&rfr_iscdi=true |